Login | Register

New Orphan Drug Kynamro Approved For Inherited Cholesterol Disorder

Kynamro (mipomersen sodium) injection has been approved by the FDA to treat people who are genetically predisposed to have high levels of LDL cholesterol - what lay people refer to as "bad cholesterol". Kynamro was approved to be taken together with lipid-lowering drugs and diet for patients with HoFH (homozygous familial hypercholesterolemia)...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *